Effects of ketoconazole on digoxin absorption and disposition in rat

Pharmacology
L Salphati, L Z Benet

Abstract

Digoxin, a cardiac glycoside, is a substrate of the multidrug transporter P-glycoprotein (Pgp), and in rats has also been identified as a substrate for cytochrome P450 3A (CYP3A). Ketoconazole, an antifungal agent, was shown to inhibit Pgp in a multidrug-resistant cell line, and is known to be a potent inhibitor of CYP3A. Here, we determined the effects of ketoconazole on digoxin absorption and disposition in rats. Digoxin was administered intravenously or orally with or without a concomitant oral dose of ketoconazole. When given intravenously, digoxin AUC increased from 93 +/- 22 to 486 +/- 26 microg x h/l with ketoconazole administration. Similarly, ketoconazole raised the AUC of orally administered digoxin from 63 +/- 17 to 411 +/- 50 microg x h/l. Concomitant ketoconazole administration prolonged digoxin elimination, yielding a nonlinear pharmacokinetic profile. Using time-averaged values, digoxin bioavailability increased from 0.68 +/- 0.18 to 0.84 +/- 0.10, while mean absorption time was reduced from 1.1 +/- 0.4 to 0.3 +/- 0.1 h. Thus, in rats, ketoconazole increases digoxin plasma concentrations, rate of absorption and bioavailability. Although the effects of ketoconazole on AUC could be explained by inhibition of both C...Continue Reading

Citations

Oct 17, 2003·Archives of Pharmacal Research·Hongjian ZhangSaeho Chong
Sep 21, 2004·Cancer Chemotherapy and Pharmacology·Candice JamoisLaurence Bonhomme-Faivre
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Z BenetV J Wacher
Sep 29, 2001·Advanced Drug Delivery Reviews·L Z Benet, C L Cummins
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·H Suzuki, Y Sugiyama
Jul 18, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M SababiU Hultkvist-Bengtsson
Nov 25, 2000·Journal of Pharmacological and Toxicological Methods·M M CotreauD J Greenblatt
Dec 13, 2006·Drug Metabolism and Drug Interactions·Krishna K MachavaramMadhusudan R Yamsani
Dec 13, 2006·Drug Metabolism and Drug Interactions·Srirangam RameshYamsani Madhusudan Rao
Mar 23, 2011·Drug Metabolism and Drug Interactions·Yamsani Shravan KumarYamsani Madhusudan Rao
Aug 26, 1999·Drug Metabolism Reviews·M Strolin Benedetti, M Bani
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·V Hayden ThomasAyman El-Kattan
Mar 6, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Etienne CouseinPascal Odou
Nov 18, 2003·British Journal of Clinical Pharmacology·Lynn PurkinsDon Nichols
Feb 24, 2011·Journal of Clinical Pharmacology·Michael WeissWerner Siegmund
Oct 17, 2012·Journal of Veterinary Pharmacology and Therapeutics·G-Y WangS-X Jiang
Mar 19, 2011·Expert Opinion on Therapeutic Patents·Naseem AkhtarSushama Talegaonkar
Sep 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Kazuto YasudaErin G Schuetz
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Carolyn L CumminsLeslie Z Benet
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Celine VeauRobert Farinotti
Oct 6, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Chuang LuSuresh K Balani
Jun 23, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Chuang LuLiang-Shang Gan
Sep 27, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S V MandlekarP H Marathe
May 15, 2002·Pharmacology & Toxicology·Gert Fricker, David S Miller
Dec 3, 1999·British Journal of Clinical Pharmacology·N BrynneL Bertilsson
Jan 19, 2021·Biomedical Chromatography : BMC·Sara Batista do NascimentoWhocely Victor de Castro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.